10:30 ET
Clinical Chemistry Analyzers Market worth $20.86 billion by 2030 | MarketsandMarkets™
The clinical chemistry analyzers market is projected to grow from $25.92 billion in 2025 to $20.86 billion by 2030, at a CAGR of 5.6%. Growth is driven by rising chronic diseases, an aging population, and point-of-care testing. North America leads the market, with hospitals & clinics as the largest end-user segment. Lipid profile tests are expected to grow fastest due to obesity-related health issues. Major companies include Abbott Laboratories, Roche, and Siemens Healthineers.
prnewswire·